Association of Biomarker and Physiologic Indices With Mortality in Older Adults: Cardiovascular Health Study

Jason L. Sanders, Alice M. Arnold, Robert M. Boudreau, Calvin H. Hirsch, Jorge Kizer, Robert C. Kaplan, Anne R. Cappola, Mary Cushman, Mini E. Jacob, Stephen B. Kritchevsky, Anne B. Newman

Research output: Contribution to journalArticle

  • 1 Citations

Abstract

Background: A goal of gerontology is discovering aging phenotypes that reflect biological aging distinct from disease pathogenesis. Biomarkers that strongly and independently associated with mortality and that statistically attenuated chronologic age could be used to define such a phenotype. We determined the association of a Biomarker Index (BI) with mortality and compared it with a validated Physiologic Index (PI) in older adults. Methods: The indices were constructed in the Cardiovascular Health Study, mean (SD) age 74.5 (5.1) years. The BI incorporated circulating levels of new biomarkers, including insulin-like growth factor-1, insulin-like growth factor-binding protein 3, amino-terminal pro-B-type natriuretic peptide, dehydroepiandrosterone sulfate, and interleukin-6, and was built in test (N = 2,197) and validation (N = 1,124) samples. The PI included carotid intima-media thickness, pulmonary capacity, brain white matter grade, cystatin-C, and fasting glucose. Multivariable Cox proportional hazards models predicting death were calculated with 10 years of follow-up. Results: In separate age-adjusted models, the hazard ratio for mortality per point of the BI was 1.30 (95% confidence interval 1.25, 1.34) and the BI attenuated age by 25%. The hazard ratio for the PI was 1.28 (1.24, 1.33; 29% age attenuation). In the same model, the hazard ratio for the BI was 1.23 (1.18, 1.28) and for the PI was 1.22 (1.17, 1.26), and age was attenuated 42.5%. Associations persisted after further adjustment. Conclusions: The BI and PI were significantly and independently associated with mortality. Both attenuated the age effect on mortality substantially. The indices may be feasible phenotypes for developing interventions hoping to alter the trajectory of aging.

LanguageEnglish (US)
Pages114-120
Number of pages7
JournalThe journals of gerontology. Series A, Biological sciences and medical sciences
Volume74
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Biomarkers
Mortality
Health
Proportional Hazards Models
Phenotype
Lung Volume Measurements
Social Adjustment
Cystatin C
Carotid Intima-Media Thickness
Dehydroepiandrosterone Sulfate
Insulin-Like Growth Factor Binding Protein 3
Brain Natriuretic Peptide
Somatomedins
Geriatrics
Interleukin-6
Fasting
Confidence Intervals
Glucose
Brain

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Association of Biomarker and Physiologic Indices With Mortality in Older Adults : Cardiovascular Health Study. / Sanders, Jason L.; Arnold, Alice M.; Boudreau, Robert M.; Hirsch, Calvin H.; Kizer, Jorge; Kaplan, Robert C.; Cappola, Anne R.; Cushman, Mary; Jacob, Mini E.; Kritchevsky, Stephen B.; Newman, Anne B.

In: The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 74, No. 1, 01.01.2019, p. 114-120.

Research output: Contribution to journalArticle

Sanders, Jason L. ; Arnold, Alice M. ; Boudreau, Robert M. ; Hirsch, Calvin H. ; Kizer, Jorge ; Kaplan, Robert C. ; Cappola, Anne R. ; Cushman, Mary ; Jacob, Mini E. ; Kritchevsky, Stephen B. ; Newman, Anne B. / Association of Biomarker and Physiologic Indices With Mortality in Older Adults : Cardiovascular Health Study. In: The journals of gerontology. Series A, Biological sciences and medical sciences. 2019 ; Vol. 74, No. 1. pp. 114-120.
@article{2800203d566d415d81d78b565bc46a2f,
title = "Association of Biomarker and Physiologic Indices With Mortality in Older Adults: Cardiovascular Health Study",
abstract = "Background: A goal of gerontology is discovering aging phenotypes that reflect biological aging distinct from disease pathogenesis. Biomarkers that strongly and independently associated with mortality and that statistically attenuated chronologic age could be used to define such a phenotype. We determined the association of a Biomarker Index (BI) with mortality and compared it with a validated Physiologic Index (PI) in older adults. Methods: The indices were constructed in the Cardiovascular Health Study, mean (SD) age 74.5 (5.1) years. The BI incorporated circulating levels of new biomarkers, including insulin-like growth factor-1, insulin-like growth factor-binding protein 3, amino-terminal pro-B-type natriuretic peptide, dehydroepiandrosterone sulfate, and interleukin-6, and was built in test (N = 2,197) and validation (N = 1,124) samples. The PI included carotid intima-media thickness, pulmonary capacity, brain white matter grade, cystatin-C, and fasting glucose. Multivariable Cox proportional hazards models predicting death were calculated with 10 years of follow-up. Results: In separate age-adjusted models, the hazard ratio for mortality per point of the BI was 1.30 (95{\%} confidence interval 1.25, 1.34) and the BI attenuated age by 25{\%}. The hazard ratio for the PI was 1.28 (1.24, 1.33; 29{\%} age attenuation). In the same model, the hazard ratio for the BI was 1.23 (1.18, 1.28) and for the PI was 1.22 (1.17, 1.26), and age was attenuated 42.5{\%}. Associations persisted after further adjustment. Conclusions: The BI and PI were significantly and independently associated with mortality. Both attenuated the age effect on mortality substantially. The indices may be feasible phenotypes for developing interventions hoping to alter the trajectory of aging.",
author = "Sanders, {Jason L.} and Arnold, {Alice M.} and Boudreau, {Robert M.} and Hirsch, {Calvin H.} and Jorge Kizer and Kaplan, {Robert C.} and Cappola, {Anne R.} and Mary Cushman and Jacob, {Mini E.} and Kritchevsky, {Stephen B.} and Newman, {Anne B.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1093/gerona/gly075",
language = "English (US)",
volume = "74",
pages = "114--120",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Association of Biomarker and Physiologic Indices With Mortality in Older Adults

T2 - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

AU - Sanders, Jason L.

AU - Arnold, Alice M.

AU - Boudreau, Robert M.

AU - Hirsch, Calvin H.

AU - Kizer, Jorge

AU - Kaplan, Robert C.

AU - Cappola, Anne R.

AU - Cushman, Mary

AU - Jacob, Mini E.

AU - Kritchevsky, Stephen B.

AU - Newman, Anne B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: A goal of gerontology is discovering aging phenotypes that reflect biological aging distinct from disease pathogenesis. Biomarkers that strongly and independently associated with mortality and that statistically attenuated chronologic age could be used to define such a phenotype. We determined the association of a Biomarker Index (BI) with mortality and compared it with a validated Physiologic Index (PI) in older adults. Methods: The indices were constructed in the Cardiovascular Health Study, mean (SD) age 74.5 (5.1) years. The BI incorporated circulating levels of new biomarkers, including insulin-like growth factor-1, insulin-like growth factor-binding protein 3, amino-terminal pro-B-type natriuretic peptide, dehydroepiandrosterone sulfate, and interleukin-6, and was built in test (N = 2,197) and validation (N = 1,124) samples. The PI included carotid intima-media thickness, pulmonary capacity, brain white matter grade, cystatin-C, and fasting glucose. Multivariable Cox proportional hazards models predicting death were calculated with 10 years of follow-up. Results: In separate age-adjusted models, the hazard ratio for mortality per point of the BI was 1.30 (95% confidence interval 1.25, 1.34) and the BI attenuated age by 25%. The hazard ratio for the PI was 1.28 (1.24, 1.33; 29% age attenuation). In the same model, the hazard ratio for the BI was 1.23 (1.18, 1.28) and for the PI was 1.22 (1.17, 1.26), and age was attenuated 42.5%. Associations persisted after further adjustment. Conclusions: The BI and PI were significantly and independently associated with mortality. Both attenuated the age effect on mortality substantially. The indices may be feasible phenotypes for developing interventions hoping to alter the trajectory of aging.

AB - Background: A goal of gerontology is discovering aging phenotypes that reflect biological aging distinct from disease pathogenesis. Biomarkers that strongly and independently associated with mortality and that statistically attenuated chronologic age could be used to define such a phenotype. We determined the association of a Biomarker Index (BI) with mortality and compared it with a validated Physiologic Index (PI) in older adults. Methods: The indices were constructed in the Cardiovascular Health Study, mean (SD) age 74.5 (5.1) years. The BI incorporated circulating levels of new biomarkers, including insulin-like growth factor-1, insulin-like growth factor-binding protein 3, amino-terminal pro-B-type natriuretic peptide, dehydroepiandrosterone sulfate, and interleukin-6, and was built in test (N = 2,197) and validation (N = 1,124) samples. The PI included carotid intima-media thickness, pulmonary capacity, brain white matter grade, cystatin-C, and fasting glucose. Multivariable Cox proportional hazards models predicting death were calculated with 10 years of follow-up. Results: In separate age-adjusted models, the hazard ratio for mortality per point of the BI was 1.30 (95% confidence interval 1.25, 1.34) and the BI attenuated age by 25%. The hazard ratio for the PI was 1.28 (1.24, 1.33; 29% age attenuation). In the same model, the hazard ratio for the BI was 1.23 (1.18, 1.28) and for the PI was 1.22 (1.17, 1.26), and age was attenuated 42.5%. Associations persisted after further adjustment. Conclusions: The BI and PI were significantly and independently associated with mortality. Both attenuated the age effect on mortality substantially. The indices may be feasible phenotypes for developing interventions hoping to alter the trajectory of aging.

UR - http://www.scopus.com/inward/record.url?scp=85053178870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053178870&partnerID=8YFLogxK

U2 - 10.1093/gerona/gly075

DO - 10.1093/gerona/gly075

M3 - Article

VL - 74

SP - 114

EP - 120

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 1

ER -